Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3180106 | Actas Dermo-Sifiliográficas | 2015 | 10 Pages |
Abstract
Disease course in melanoma often cannot be accurately predicted by means of the prognostic factors usually considered in patients with melanoma; therefore, new factors are clearly needed. Increasingly robust scientific evidence shows that tumor lymph vessels play a key role in melanoma that metastasizes by lymphatic and hematogenous pathways. We review current knowledge and examine the implications of lymphangiogenesis in the diagnosis, treatment, and prognosis of patients with melanoma.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
I. Pastushenko, C. Conejero, F.J. Carapeto,